Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nephros Inc (NEPH)
NASDAQ:NEPH
Holding NEPH?
Track your performance easily
NEPH Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.40 - $4.04
Previous Close$1.8
Volume6.22K
Average Volume (3M)11.04K
Market Cap
$18.98M
Enterprise Value$15.90M
Total Cash (Recent Filing)$3.08M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.97
Next Earnings
Nov 06, 2024EPS Estimate
-$0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.12
Shares Outstanding10,544,139
10 Day Avg. Volume2,723
30 Day Avg. Volume11,035
Standard Deviation0.19
R-Squared0.11
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)2.41
Price to Sales (P/S)1.38
Price to Cash Flow (P/CF)-9.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.15
Enterprise Value/Gross Profit1.89
Enterprise Value/Ebitda-14.26
Forecast
1Y Price Target
$4.75Price Target Upside163.16% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Nephros News
PremiumCompany Announcements
Nephros Shares 2024 Corporate Outlook and Plans
PremiumCompany Announcements
Nephros Inc to Present Corporate Strategies at Showcase
Ownership Overview
40.88% Insiders
2.52% Mutual Funds
38.20% Other Institutional Investors
18.39% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
NEPH FAQ
What was Nephros Inc’s price range in the past 12 months?
Nephros Inc lowest stock price was $1.40 and its highest was $4.04 in the past 12 months.
What is Nephros Inc’s market cap?
Currently, no data Available
When is Nephros Inc’s upcoming earnings report date?
Nephros Inc’s upcoming earnings report date is Nov 06, 2024 which is in 47 days.
How were Nephros Inc’s earnings last quarter?
Nephros Inc released its earnings results on Aug 08, 2024. The company reported -$0.03 earnings per share for the quarter, missing the consensus estimate of -$0.015 by -$0.015.
Is Nephros Inc overvalued?
According to Wall Street analysts Nephros Inc’s price is currently Undervalued.
Does Nephros Inc pay dividends?
Nephros Inc does not currently pay dividends.
What is Nephros Inc’s EPS estimate?
Nephros Inc’s EPS estimate is -$0.02.
How many shares outstanding does Nephros Inc have?
Nephros Inc has 10,544,139 shares outstanding.
What happened to Nephros Inc’s price movement after its last earnings report?
Nephros Inc reported an EPS of -$0.03 in its last earnings report, missing expectations of -$0.015. Following the earnings report the stock price went down -8.411%.
Which hedge fund is a major shareholder of Nephros Inc?
Among the largest hedge funds holding Nephros Inc’s share is Wexford Capital LP. It holds Nephros Inc’s shares valued at 8M.
---
Nephros Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.75 (163.16% Upside)
$4.75 (163.16% Upside)
Hedge Fund Trend
Increased
By 36.0K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
26.76%
12-Months-Change
Fundamentals
Return on Equity
-15.61%
Trailing 12-Months
Asset Growth
6.87%
Trailing 12-Months
Company Description
Nephros Inc
Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company operates in two segments: Water Filtration and Renal Products. The Water Filtration segment includes both the medical device and commercial filtration product lines. The Renal Products segment comprises of SRP, which is focused on the development of medical device products for patients with renal disease, including a second-generation HDF system for the treatment of patients with ESRD. Its ultrafilters are used in dialysis centers for the removal of biological contaminants from water, bicarbonate concentrate and blood. The company was founded on April 3, 1997 and is headquartered in South Orange, NJ.
---
NEPH Earnings Call
Q2 2024
0:00 / 0:00
---
NEPH Stock 12 Month Forecast
Average Price Target
$4.75
▲(163.16% Upside)
Technical Analysis
Best Analysts Covering NEPH
1 Year
1 Year Success Rate
9/24 ratings generated profit
1 Year Average Return
-8.08%
reiterated a buy rating last month
Copying Anthony Vendetti's trades and holding each position for 1 Year would result in 37.50% of your transactions generating a profit, with an average return of -8.08% per trade.
---